Share this post on:

Product Name :
AVD-104

Search keywords :
Factor H

drugId :
null

Target Vo:
Complement factor H

Target Vo Short Name :
CFH

Moa_Name:
Immunomodulators

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Aviceda Therapeutics Llc

Active Company_Name :
Aviceda Therapeutics Inc

Active Indication_Name:
Geographic Atrophy

In Active Indication_Name:
Diabetic macular oedema

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
CaMKII alpha Rabbit mAb site
Inotuzumab ADC Antibody
AKT1 Antibody (YA834): AKT1 Antibody (YA834) is a non-conjugated and Mouse origined monoclonal antibody about 56 kDa, targeting to AKT1. It can be used for WB,ICC,IHC-P,FC assays with tag free, in the background of Human.

Share this post on:

Author: Interleukin Related